Published in J Virol on April 01, 1975
Methylation-dependent translation of viral messenger RNAs in vitro. Proc Natl Acad Sci U S A (1975) 5.02
Transcription and replication of rhabdoviruses. Microbiol Rev (1987) 4.05
Separate pathways of maturation of the major structural proteins of vesicular stomatitis virus. J Virol (1977) 4.03
Localization of two cellular forms of the vesicular stomatitis viral glycoprotein. J Virol (1977) 3.20
Coding assignments of double-stranded RNA segments of SA 11 rotavirus established by in vitro translation. J Virol (1980) 3.10
5'-terminal sequence of vesicular stomatitis virus mRNA's synthesized in vitro. J Virol (1975) 2.73
Analysis of the 3'-terminal nucleotide sequence of vesicular stomatitis virus N protein mRNA. Nucleic Acids Res (1978) 2.68
Synthesis of Rauscher murine leukemia virus-specific polypeptides in vitro. Proc Natl Acad Sci U S A (1976) 2.36
Synthesis of vesicular stomatitis virus negative-strand RNA in vitro: dependence on viral protein synthesis. J Virol (1982) 2.28
Nucleotide sequences of ribosome recgonition sites in messenger RNAs of vesicular stomatitis virus. Proc Natl Acad Sci U S A (1977) 2.05
Synthesis and glycosylation in vitro of glycoprotein of vesicular stomatitis virus. Proc Natl Acad Sci U S A (1977) 1.95
Giant heterogeneous polyadenylic acid on vesicular stomatitis virus mRNA synthesized in vitro in the presence of S-adenosylhomocysteine. J Virol (1977) 1.80
Characterization of the mRNA of influenza virus. J Virol (1975) 1.71
Cellular and cell-free synthesis of simian virus 40 T-antigens in permissive and transformed cells. J Virol (1978) 1.66
Characterization of infectious hematopoietic necrosis virus mRNA species reveals a nonvirion rhabdovirus protein. J Virol (1985) 1.55
Coupled in vitro transcription and translation of vesicular stomatitis virus messenger RNA. Proc Natl Acad Sci U S A (1975) 1.48
Vesicular stomatitis virus glycoprotein is anchored to intracellular membranes near its carboxyl end and is proteolytically cleaved at its amino terminus. J Virol (1979) 1.47
Transcriptional mapping of vesicular stomatitis virus in vivo. J Virol (1977) 1.45
Alterations in the protein synthetic apparatus of Friend erythroleukemia cells infected with vesicular stomatitis virus or herpes simplex virus. J Virol (1978) 1.45
RNA- temperature-sensitive mutants of vesicular stomatitis virus: L-protein thermosensitivity accounts for transcriptase restriction of group I mutants. J Virol (1976) 1.44
Differential inhibition of vesicular stomatitis virus polypeptide synthesis by hypertonic initiation block. J Virol (1975) 1.33
Inhibition by aurintricarboxylic acid and polyethylene sulfonate of RNA transcription of vesicular stomatitis virus. J Virol (1975) 1.21
RNA synthesis of vesicular stomatitis virus. VII. Complete separation of the mRNA's of vesicular stomatitis virus by duplex formation. J Virol (1977) 1.20
Assembly of viral membranes: nature of the association of vesicular stomatitis virus proteins to membranes. J Virol (1978) 1.17
Characterization of vesicular stomatitis virus mRNA species synthesized in vitro. J Virol (1977) 1.14
Differential effect of ATP concentration on synthesis of vesicular stomatitis virus leader RNAs and mRNAs. J Virol (1987) 1.08
Cell-free translation of RNA synthesized in vitro by a transcribing nucleoprotein complex prepared from purified vesicular stomatitis virus. J Virol (1977) 1.04
Assembly of viral membranes: maturation of the vesicular stomatitis virus glycoprotein in the presence of tunicamycin. J Virol (1978) 1.02
Studies on the mechanism for entry of vesicular stomatitis virus glycoprotein G mRNA into membrane-bound polyribosome complexes. J Cell Biol (1977) 0.89
Translation of individual host mRNA's in MPC-11 cells is differentially suppressed after infection by vesicular stomatitis virus. J Virol (1976) 0.86
Assembly of vesicular stomatitis virus: distribution of the glycoprotein on the surface of infected cells. J Virol (1982) 0.81
Rifampin-susceptible mutant of vesicular stomatitis virus: protein and RNA synthesis. J Virol (1977) 0.79
Processing of adenovirus 2-induced proteins. J Virol (1973) 12.52
Comparative sedimentation coefficients of RNA extracted from plaque-forming and defective particles of vesicular stomatitis virus. J Mol Biol (1966) 6.61
Ribonucleic acid synthesis of vesicular stomatitis virus. 3. Multiple complementary messenger RNA molecules. Virology (1970) 5.99
Proteins of vesicular stomatitis virus: kinetics and cellular sites of synthesis. J Virol (1970) 4.85
Polysomal ribonucleic acid of vesicular stomatitis virus-infected HeLa cells. Virology (1970) 4.85
Translation and identification of the mRNA species synthesized in vitro by the virion-associated RNA polymerase of vesicular stomatitis virus. Proc Natl Acad Sci U S A (1975) 4.17
In vitro synthesis of RNA that contains polyadenylate by virion-associated RNA polymerase of vesicular stomatitis virus. Proc Natl Acad Sci U S A (1973) 3.17
Translation of vesicular stomatitis messenger RNA by extracts from mammalian and plant cells. J Virol (1974) 3.06
Messenger RNA species synthesized in vitro by the virion-associated RNA polymerase of vesicular stomatitis virus. Cell (1975) 3.04
Cytoplasmic compartmentalization of the protein and ribonucleic acid species of vesicular stomatitis virus. J Virol (1972) 2.37
Membrane-associated protein synthesis of mammalian cells. I. The two classes of membrane-associated ribosomes. J Mol Biol (1971) 2.09
Phosphorylation of vesicular stomatitis virus in vivo and in vitro. J Virol (1974) 2.07
Replication of vesicular stomatitis virus. II. Separation and characterization of virus-specific RNA species. Virology (1972) 1.98
Sub-cellular localization of vesicular stomatitis virus messenger RNAs. Biochem Biophys Res Commun (1975) 1.91
In vitro synthesis of proteins by membrane-bound polyribosomes from vesicular stomatitis virus-infected HeLa cells. J Virol (1974) 1.90
Replication of vesicular stomatitis virus. I. Viral specific RNA and nucleoprotein in infected L cells. Virology (1970) 1.77
Replication of vesicular stomatitis virus: characterization of the virus-induced RNA. J Gen Virol (1971) 1.56
Vesicular stomatitis virus envelope glycoprotein alterations induced by host cell transformation. Cell (1974) 1.45
Synthesis in vitro of vesicular stomatitis virus proteins in cytoplasmic extracts of L cells. Biochem Biophys Res Commun (1973) 1.31
5'-terminal cap structure in eucaryotic messenger ribonucleic acids. Microbiol Rev (1980) 6.14
Sequential transcription of the genes of vesicular stomatitis virus. Proc Natl Acad Sci U S A (1976) 5.88
Methylation-dependent translation of viral messenger RNAs in vitro. Proc Natl Acad Sci U S A (1975) 5.02
Exclusion of elderly people from clinical research: a descriptive study of published reports. BMJ (1997) 4.95
5'-Terminal 7-methylguanosine in eukaryotic mRNA is required for translation. Nature (1975) 4.45
The 5' terminal structure of the methylated mRNA synthesized in vitro by vesicular stomatitis virus. Cell (1975) 4.43
Translation and identification of the mRNA species synthesized in vitro by the virion-associated RNA polymerase of vesicular stomatitis virus. Proc Natl Acad Sci U S A (1975) 4.17
Transcription and replication of rhabdoviruses. Microbiol Rev (1987) 4.05
A unique RNA species involved in initiation of vesicular stomatitis virus RNA transcription in vitro. Cell (1976) 3.82
Antigenic drift in influenza virus H3 hemagglutinin from 1968 to 1980: multiple evolutionary pathways and sequential amino acid changes at key antigenic sites. J Virol (1983) 3.70
Oxygen desaturation during endoscopy in the elderly. J R Coll Physicians Lond (1993) 3.37
In vitro synthesis of RNA that contains polyadenylate by virion-associated RNA polymerase of vesicular stomatitis virus. Proc Natl Acad Sci U S A (1973) 3.17
Transcription in vitro by reovirus-associated ribonucleic acid-dependent polymerase. J Virol (1970) 3.07
Complete nucleotide sequence of the leader RNA synthesized in vitro by vesicular stomatitis virus. Cell (1978) 3.06
Messenger RNA species synthesized in vitro by the virion-associated RNA polymerase of vesicular stomatitis virus. Cell (1975) 3.04
Studies on the in vitro adenylation of RNA by vesicular stomatitis virus. Virology (1974) 2.83
Ribosome binding to reovirus mRNA in protein synthesis requires 5' terminal 7-methylguanosine. Cell (1975) 2.78
5'-terminal sequence of vesicular stomatitis virus mRNA's synthesized in vitro. J Virol (1975) 2.73
Complexes of Sendai virus NP-P and P-L proteins are required for defective interfering particle genome replication in vitro. J Virol (1992) 2.73
Serotype-specific glycoprotein of simian 11 rotavirus: coding assignment and gene sequence. Proc Natl Acad Sci U S A (1983) 2.46
Tubulin: a factor necessary for the synthesis of both Sendai virus and vesicular stomatitis virus RNAs. Proc Natl Acad Sci U S A (1986) 2.45
In vitro synthesis of methylated messenger RNA by the virion-associated RNA polymerase of vesicular stomatitis virus. Cell (1974) 2.42
Synthesis of all the gene products of the reovirus genome in vivo and in vitro. Cell (1975) 2.42
Unique mode of transcription in vitro by Vesicular stomatitis virus. Cell (1980) 2.36
Novel initiation of RNA synthesis in vitro by vesicular stomatitis virus. Nature (1975) 2.36
Conservation and variation in the hemagglutinins of Hong Kong subtype influenza viruses during antigenic drift. J Virol (1981) 2.35
Rescue of synthetic analogs of genome RNA of human parainfluenza virus type 3. Virology (1993) 2.33
Evidence for an accumulation of messenger RNA specific for extracellular protease and its relevance to the mechanism of enzyme secretion in bacteria. J Mol Biol (1972) 2.29
Hemagglutinin of swine influenza virus: a single amino acid change pleiotropically affects viral antigenicity and replication. Proc Natl Acad Sci U S A (1983) 2.28
An infectious clone of human parainfluenza virus type 3. J Virol (1997) 2.28
Improving cancer radiotherapy with 2-deoxy-D-glucose: phase I/II clinical trials on human cerebral gliomas. Int J Radiat Oncol Biol Phys (1996) 2.15
Methylated and blocked 5' termini in vesicular stomatitis virus in vivo mRNAs. Cell (1975) 2.15
A new method for the size estimation of the RNA genome segments of influenza virus. Nucleic Acids Res (1979) 2.12
Viral proteins required for the in vitro replication of vesicular stomatitis virus defective interfering particle genome RNA. Virology (1988) 2.11
Assembly of vesicular stomatitis virus glycoprotein and matrix protein into HeLa cell plasma membranes. J Mol Biol (1976) 2.10
Antigenic drift in the hemagglutinin of the Hong Kong influenza subtype: correlation of amino acid changes with alterations in viral antigenicity. J Virol (1981) 2.09
Phosphorylation of vesicular stomatitis virus in vivo and in vitro. J Virol (1974) 2.07
Phosphorylation by cellular casein kinase II is essential for transcriptional activity of vesicular stomatitis virus phosphoprotein P. Proc Natl Acad Sci U S A (1992) 2.03
Influence of 5'-terminal m7G and 2'--O-methylated residues on messenger ribonucleic acid binding to ribosomes. Biochemistry (1976) 1.99
The influenza virus haemagglutinin gene: cloning and characterisation of a double-stranded DNA copy. Nucleic Acids Res (1979) 1.98
Initiation and replication of vesicular stomatitis virus genome RNA in a cell-free system. Proc Natl Acad Sci U S A (1983) 1.95
Phosphorylation within a specific domain of the phosphoprotein of vesicular stomatitis virus regulates transcription in vitro. Cell (1987) 1.92
Intervening polyadenylate sequences in RNA transcripts of vesicular stomatitis virus. Cell (1978) 1.92
Sub-cellular localization of vesicular stomatitis virus messenger RNAs. Biochem Biophys Res Commun (1975) 1.91
Complex formation with vesicular stomatitis virus phosphoprotein NS prevents binding of nucleocapsid protein N to nonspecific RNA. J Virol (1988) 1.91
Nucleotide sequence coding for the N-terminal region of the matrix protein influenza virus. Eur J Biochem (1979) 1.90
Temporal regulation of influenza hemagglutinin expression in vaccinia virus recombinants and effects on the immune response. Eur J Immunol (1986) 1.90
Sequential phosphorylation of the phosphoprotein of vesicular stomatitis virus by cellular and viral protein kinases is essential for transcription activation. J Virol (1992) 1.88
Identification of a domain within the phosphoprotein of vesicular stomatitis virus that is essential for transcription in vitro. Proc Natl Acad Sci U S A (1986) 1.87
Effect of 5'-terminal structure and base composition on polyribonucleotide binding to ribosomes. J Mol Biol (1976) 1.84
A general strategy for cloning double-stranded RNA: nucleotide sequence of the Simian-11 rotavirus gene 8. Nucleic Acids Res (1982) 1.83
Requirements and functions of vesicular stomatitis virus L and NS proteins in the transcription process in vitro. Biochem Biophys Res Commun (1985) 1.79
Parasitic infections of the lung: a guide for the respiratory physician. Thorax (2010) 1.78
Mapping and initiation studies on the leader RNA of vesicular stomatitis virus. Virology (1977) 1.78
Vesicular stomatitis virus NS proteins: structural similarity without extensive sequence homology. J Virol (1985) 1.73
Transcriptional activity and mutational analysis of recombinant vesicular stomatitis virus RNA polymerase. J Virol (1993) 1.73
Coding assignment and nucleotide sequence of simian rotavirus SA11 gene segment 10: location of glycosylation sites suggests that the signal peptide is not cleaved. J Virol (1983) 1.72
Deletions into an NH2-terminal hydrophobic domain result in secretion of rotavirus VP7, a resident endoplasmic reticulum membrane glycoprotein. J Cell Biol (1985) 1.70
Rotavirus neutralizing protein VP7: antigenic determinants investigated by sequence analysis and peptide synthesis. J Virol (1985) 1.69
Complete nucleotide sequence of the haemagglutinin gene from a human influenza virus of the Hong Kong subtype. Nucleic Acids Res (1980) 1.64
Mapping of interacting domains between the nucleocapsid protein and the phosphoprotein of vesicular stomatitis virus by using a two-hybrid system. Proc Natl Acad Sci U S A (1993) 1.63
Initiation of reovirus mRNA synthesis in vitro. Nat New Biol (1971) 1.61
Cloning and expression of the vesicular stomatitis virus phosphoprotein gene in Escherichia coli: analysis of phosphorylation status versus transcriptional activity. J Virol (1991) 1.60
Simultaneous pulmonary and cerebral oedema, and multiple CNS infarctions as complications of diabetic ketoacidosis: a case report. Diabet Med (2006) 1.60
The nature of the RNA products synthesized in vitro by subviral components of visicular stomatitis virus. Virology (1976) 1.60
Resolution of multiple complexes of phosphoprotein NS with nucleocapsid protein N of vesicular stomatitis virus. J Virol (1988) 1.57
Dynamic state of the messenger RNA pool specific for extracellular protease in Bacillus amyloliquefaciens: its relevance to the mechanism of enzyme secretion. J Mol Biol (1973) 1.55
Common variable immune deficiency: respiratory manifestations, pulmonary function and high-resolution CT scan findings. QJM (2002) 1.54
In vitro replication of Sendai virus wild-type and defective interfering particle genome RNAs. J Virol (1985) 1.53
In vitro synthesis of messenger RNA by a defective interfering particle of vesicular stomatitis virus. Proc Natl Acad Sci U S A (1977) 1.51
Endoscopic transthoracic sympathectomy in the treatment of hyperhidrosis. Ann Surg (1992) 1.51
Does a doctor's dress-style matter? Med J Aust (1988) 1.49
RNA polymerase of vesicular stomatitis virus specifically associates with translation elongation factor-1 alphabetagamma for its activity. Proc Natl Acad Sci U S A (1998) 1.49
Complications of parotid surgery: the need for selectivity. Br J Surg (1989) 1.48
In vitro phosphorylation of NS protein by the L protein of vesicular stomatitis virus. J Gen Virol (1985) 1.48
The signal peptide of the rotavirus glycoprotein VP7 is essential for its retention in the ER as an integral membrane protein. Cell (1989) 1.47
Vesicular stomatitis virus envelope glycoprotein alterations induced by host cell transformation. Cell (1974) 1.45
Deletion analysis defines a carboxyl-proximal region of Sendai virus P protein that binds to the polymerase L protein. Virology (1994) 1.44
RNA editing in the phosphoprotein gene of the human parainfluenza virus type 3. Virology (1992) 1.44
In vitro RNA transcription by the New Jersey serotype of vesicular stomatitis virus. I. Characterization of the mRNA species. J Virol (1978) 1.44
Completion of the genomic sequence of the simian rotavirus SA11: nucleotide sequences of segments 1, 2, and 3. Virology (1990) 1.43
Initiation of RNA synthesis in vitro by vesicular stomatitis virus. Role of ATP. J Biol Chem (1979) 1.43
Two methyltransferase activities in the purified virions of vesicular stomatitis virus. J Virol (1977) 1.42
Replication of RNA viruses. X. Replication of a natural 6 s RNA by the Q-beta RNA polymerase. J Mol Biol (1969) 1.42
The Sendai virus C protein binds the L polymerase protein to inhibit viral RNA synthesis. Virology (1997) 1.41
Ovine adenovirus vectors overcome preexisting humoral immunity against human adenoviruses in vivo. J Virol (1999) 1.40
Oligosaccharide moieties of the glycoprotein of vesicular stomatitis virus. J Virol (1976) 1.40
Guanosine-5'-diphosphate at the 5' termini of reovirus RNA: evidence for a segmented genome within the virion. J Mol Biol (1971) 1.40
The Sendai virus V protein interacts with the NP protein to regulate viral genome RNA replication. Virology (1996) 1.40
Specific interactions of vesicular stomatitis virus L and NS proteins with heterologous genome ribonucleoprotein template lead to mRNA synthesis in vitro. J Virol (1984) 1.39
Anterior tibial artery embolectomy augmented by dynamic on-table angiography. Lancet (1991) 1.39
Influence of the sequence-dependent flexure of DNA on transcription in E. coli. Nucleic Acids Res (1989) 1.39